Mice carrying a conditional Serca2flox allele for the generation of Ca2+ handling-deficient mouse models

Cell Calcium

Volumn 46, Issue 3, 2009, Pages 219-225

  Andersson, Kristin B ^a,b   Finsen, Alexandra V ^a,b   Sjåland, Cecilie ^a,b   Winer, Lisbeth H ^a,b   Sjaastad, Ivar ^a,b   Ødegaard, Annlaug ^a,b   Louch, William E ^a,b   Wang, Yibin ^c   Chen, Ju ^d   Chien, Kenneth R ^e   Sejersted, Ole M ^a,b   Christensen, Geir ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Calcium ATPase; Endoplasmic reticulum; Flox; Sarcoplasmic reticulum; Serca2; Transgenic mouse

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE FUNCTION; HEART; HETEROZYGOSITY; HOMOZYGOSITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; TISSUE LEVEL; YOLK SAC;

MURINAE; MUS; MUS MUSCULUS;

EID: 69249208432     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceca.2009.07.004     Document Type: Article

References (40)

1. 2+-ATPase. Circ. Res. 83 (1998) 889-897
2. Wuytack F., Raeymaekers L., and Missiaen L. Molecular physiology of the SERCA and SPCA pumps. Cell Calcium 32 (2002) 279-305
3. 2+-ATPase mRNA. FEBS Lett. 249 (1989) 35-41
4. 2+ pump, cause Darier disease. Nat. Genet. 21 (1999) 271-277
5. 2+]i waves. J. Biol. Chem. 272 (1997) 15771-15776
6. 2+ transport ATPase SERCA2 isoforms in the cat brain. Brain Res. 743 (1996) 141-153
7. Gelebart P., Martin V., Enouf J., et al. Identification of a new SERCA2 splice variant regulated during monocytic differentiation. Biochem. Biophys. Res. Commun. 303 (2003) 676-684
8. 2+-ATPase 2 isoform (SERCA2c). Biochem. J. 395 (2006) 249-258
9. Colucci W.S., and Braunwald E. In: Zipes D.P., Bonow R.O., and Braunwald E. (Eds). Braunwald's Heart Disease: a Textbook of Cardiovascular Medicine (2005), Elsevier Saunders 519-520
10. Hasenfuss G., and Pieske B. Calcium cycling in congestive heart failure. J. Mol. Cell Cardiol. 34 (2002) 951-969
11. 2+-ATPase modulates cardiac contraction and relaxation. Cardiovasc. Res. 57 (2003) 20-27
12. Sande J.B., Sjaastad I., Hoen I.B., et al. Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity. Cardiovasc. Res. 53 (2002) 382-391
13. 2+-ATPase isoform 2 (SERCA2) gene. J. Biol. Chem. 274 (1999) 2556-2562
14. Chen J., Kubalak S.W., Minamisawa S., et al. Selective requirement of myosin light chain 2v in embryonic heart function. J. Biol. Chem. 273 (1998) 1252-1256
15. Wredenberg A., Wibom R., Wilhelmsson H., et al. Increased mitochondrial mass in mitochondrial myopathy mice. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 15066-15071
16. Torres R.M., and Kühn R. Laboratory Protocols for Conditional Gene Targeting (1997), Oxford University Press, Oxford, NY
17. Finsen A.V., Christensen G., and Sjaastad I. Echocardiographic parameters discriminating myocardial infarction with pulmonary congestion from myocardial infarction without congestion in the mouse. J. Appl. Physiol. 98 (2005) 680-689
18. 2+-ATPase from sarcoplasmic reticulum in muscle biopsies. Biochem. J. 260 (1989) 443-448
19. Holt E., Lunde P.K., Sejersted O.M., et al. Electrical stimulation of adult rat cardiomyocytes in culture improves contractile properties and is associated with altered calcium handling. Basic Res. Cardiol. 92 (1997) 289-298
20. Andersson K.B., Florholmen G., Winer L.H., et al. Regulation of neuronal type genes in congestive heart failure rats. Acta Physiol. (Oxf.) 186 (2006) 17-27
21. Ploug T., Wojtaszewski J., Kristiansen S., et al. Glucose transport and transporters in muscle giant vesicles: differential effects of insulin and contractions. Am. J. Physiol. 264 (1993) E270-E278
22. Campbell A.M., Wuytack F., and Fambrough D.M. Differential distribution of the alternative forms of the sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase, SERCA2b and SERCA2a, in the avian brain. Brain Res. 605 (1993) 67-76
23. Minamisawa S., Gu Y., Ross Jr. J., et al. A post-transcriptional compensatory pathway in heterozygous ventricular myosin light chain 2-deficient mice results in lack of gene dosage effect during normal cardiac growth or hypertrophy. J. Biol. Chem. 274 (1999) 10066-10070
24. Lyons G.E., Schiaffino S., Sassoon D., et al. Developmental regulation of myosin gene expression in mouse cardiac muscle. J. Cell Biol. 111 (1990) 2427-2436
25. 2+ ATPase enzymatic properties using mouse cardiac tissue homogenates. Anal. Biochem. 269 (1999) 236-244
26. Ver Heyen M., Heymans S., Antoons G., et al. Replacement of the muscle-specific sarcoplasmic reticulum Ca(2+)-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart. Circ. Res. 89 (2001) 838-846
27. Schultz Jel J., Glascock B.J., Witt S.A., et al. Accelerated onset of heart failure in mice during pressure overload with chronically decreased SERCA2 calcium pump activity. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H1146-H1153
28. Talukder M.A., Kalyanasundaram A., Zuo L., et al. Is reduced SERCA2a expression detrimental or beneficial to postischemic cardiac function and injury? Evidence from heterozygous SERCA2a knockout mice. Am. J. Physiol. Heart Circ. Physiol. 294 (2008) H1426-H1434
29. Mayosi B.M., Kardos A., Davies C.H., et al. Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure. Heart 92 (2006) 105-109
30. Andersson K.B., Birkeland J.A., Finsen A.V., et al. Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene. J. Mol. Cell Cardiol. 47 (2009) 180-187
31. Burdakov D., Petersen O.H., and Verkhratsky A. Intraluminal calcium as a primary regulator of endoplasmic reticulum function. Cell Calcium 38 (2005) 303-310
32. Petersen O.H., Michalak M., and Verkhratsky A. Calcium signalling: past, present and future. Cell Calcium 38 (2005) 161-169
33. Hovnanian A. Darier's disease: from dyskeratosis to endoplasmic reticulum calcium ATPase deficiency. Biochem. Biophys. Res. Commun. 322 (2004) 1237-1244
34. Dhitavat J., Cobbold C., Leslie N., et al. Impaired trafficking of the desmoplakins in cultured Darier's disease keratinocytes. J. Invest. Dermatol. 121 (2003) 1349-1355
35. 2+ pump, predisposes mice to squamous cell tumors via a novel mode of cancer susceptibility. Cancer Res. 65 (2005) 8655-8661
36. Endo Y., Uzawa K., Mochida Y., et al. Sarcoendoplasmic reticulum Ca(2+) ATPase type 2 downregulated in human oral squamous cell carcinoma. Int. J. Cancer 110 (2004) 225-231
37. 2+-dependent exocytosis in SERCA2(±) mice. EMBO J. 20 (2001) 2680-2689
38. Verkhratsky A., and Toescu E.C. Endoplasmic reticulum Ca(2+) homeostasis and neuronal death. J. Cell. Mol. Med. 7 (2003) 351-361
39. 2+ pumps in the brain. Mol. Chem. Neuropathol. 33 (1998) 199-208
40. Lencesova L., O'Neill A., Resneck W.G., et al. Plasma membrane-cytoskeleton-endoplasmic reticulum complexes in neurons and astrocytes. J. Biol. Chem. 279 (2004) 2885-2893